Clinical Trial Update: Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating dexmedetomidine-induced sleep to minimize ICU neurological dysfunction after surgery has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Delirium
• Sleep Disorders Related to Anesthesia

Drugs mentioned

• dexmedetomidine-induced sleep (dexmedetomidine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Postoperative Delirium, Sleep | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-03-20